At the news
? BEARISHIMPACT 6/10 CLUSTER filed Feb 25, 2026 at 19:00 ET
Seven executives at Teva Pharmaceutical exercised stock derivatives and several conducted open-market sales totaling approximately $2.13 million in the past week. The transactions are primarily non-cash exercises, but significant insider selling by multiple C-suite executives suggests profit-taking at current price levels.
- Multiple C-suite executives sold shares in open-market transactions on 2026-03-05.
- Total open-market sales amounted to $2,132,043 across five insiders.
- All sales occurred at $31.6684 per share, indicating coordinated timing.
- Selling executives include EVPs of Global Operations, Europe Commercial, U.S. Commercial, Interim Chief Legal Officer, and others.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access